SG Americas Securities LLC Decreases Stock Position in Alignment Healthcare, Inc. $ALHC

SG Americas Securities LLC cut its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 82.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,605 shares of the company’s stock after selling 49,785 shares during the quarter. SG Americas Securities LLC’s holdings in Alignment Healthcare were worth $187,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of ALHC. Summit Securities Group LLC bought a new position in Alignment Healthcare during the 4th quarter valued at about $26,000. Parallel Advisors LLC raised its position in Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after purchasing an additional 773 shares during the period. Larson Financial Group LLC bought a new stake in Alignment Healthcare in the third quarter worth about $33,000. First Horizon Corp bought a new stake in Alignment Healthcare in the fourth quarter worth about $39,000. Finally, GAMMA Investing LLC lifted its stake in Alignment Healthcare by 83.8% in the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after purchasing an additional 987 shares during the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Negative Sentiment: Multiple plaintiff law firms, including Howard G. Smith, Kaplan Fox, Frank R. Cruz, Kirby McInerney, Hagens Berman, and Block & Leviton, announced investigations into possible securities-law violations and whistleblower allegations involving Alignment Healthcare. Article: Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
• Negative Sentiment: Reports that a former executive alleged accounting irregularities and inflated financial results are likely raising investor concerns about the quality of ALHC’s reported numbers and future legal risk. Article: ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation
• Neutral Sentiment: Alignment Healthcare said it will report second-quarter 2026 results on July 30, an event that could become a near-term stock catalyst if investors look for clarity on the allegations and business performance. Article: Alignment Healthcare to Announce Second Quarter 2026 Financial Results and Host Conference Call Thursday, July 30, 2026
• Neutral Sentiment: A short-interest update showed zero reported short interest, offering little incremental trading signal for ALHC. Article: Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Insiders Place Their Bets

In other news, insider Mark D. Kent purchased 14,848 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The shares were purchased at an average price of $13.31 per share, for a total transaction of $197,626.88. Following the completion of the purchase, the insider owned 14,848 shares in the company, valued at approximately $197,626.88. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $24.00, for a total value of $600,000.00. Following the completion of the sale, the executive vice president owned 1,103,816 shares of the company’s stock, valued at $26,491,584. The trade was a 2.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 854,250 shares of company stock worth $16,396,606. 5.20% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

ALHC has been the topic of a number of analyst reports. Barclays cut their target price on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Raymond James Financial set a $22.00 price target on Alignment Healthcare in a research note on Thursday, May 7th. Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Finally, KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Six research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $24.30.

Alignment Healthcare Trading Down 5.7%

Shares of Alignment Healthcare stock traded down $1.20 on Friday, hitting $19.83. 3,946,573 shares of the company traded hands, compared to its average volume of 5,119,038. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. The company has a market cap of $4.10 billion, a PE ratio of 220.33, a PEG ratio of 2.68 and a beta of 1.05. The stock’s 50 day moving average price is $19.07 and its 200-day moving average price is $19.79. Alignment Healthcare, Inc. has a 52 week low of $11.63 and a 52 week high of $25.12.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.04. The company had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.Alignment Healthcare’s revenue was up 33.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.05) earnings per share. Equities research analysts predict that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.